Twist Bioscience: Finn proposes $347K share sale
Patrick John Finn's reported prior common-stock sales span five transactions between August 3 and October 23, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Twist Bioscience Corp (TWST) is the issuer in a notice of Officer Patrick John Finn's proposed sale of 2,565 common shares. Fidelity Brokerage Services LLC is listed as broker; the shares have an aggregate market value of $347,305.36 and an approximate sale date of November 3, 2026. A separate entry lists 2,565 shares from restricted stock vesting on November 2, 2026. The remarks state that the sale includes an amount to cover a tax obligation resulting from settlement of a vested equity award distribution.
Key Figures
Key Terms
Restricted Stock Vesting financial
Rule 144 regulatory
vested equity award distribution financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What TWST stock sales did Patrick John Finn report in the prior three months?
AI-generated analysis. How Rhea-AI works. Not financial advice.